Publications by authors named "Anna Israyelyan"

Claim this Profile
D
Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.
Anna Israyelyan, Corinna La Rosa, Weimin Tsai, Teodora Kaltcheva, Tumul Srivastava

Leuk Lymphoma· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide delayed the ability of 4T1 cells to amass into tumors in Balb/c mice.
Anna Israyelyan, Felipe Sandoval, Abolghasem Baghian, Michael T Kearney, Edward J Shannon

Immunopharmacol Immunotoxicol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn.
Anna Israyelyan, Edward John Shannon, Abolghasem Baghian, Michael T Kearney, Konstantin G Kousoulas

Cancer Chemother Pharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice.
Anna Israyelyan, Vladimir N Chouljenko, Abolghasem Baghian, Andrew T David, Michael T Kearney

Virol J· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
Anna H Israyelyan, Jeffrey M Melancon, Larry G Lomax, Inder Sehgal, Carola Leuschner

Hum Gene Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis